Showing results (71-80 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|October 7, 2020
Fostamatinib: a review of its clinical efficacy and safety in the management of chronic adult immune thrombocytopeniaAdrian Newland, Vickie McDonaldImmunotherapy|October 7, 2020
Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapyCarlen A Yuen, Kourosh Rezania, Deric M Park, et al.Immunotherapy|December 3, 2019
Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumabChanakyaram A Reddy, Bryan J Schneider, Lindsay M Brackett, et al.Immunotherapy|December 5, 2018
α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8+ T-cell infiltrationHui Wang, Xiangjie Lin, Yuan Luo, et al.Immunotherapy|February 15, 2019
Delayed IL-21 treatment preferentially expands peptide-specific CD8+ T cells by reducing bystander activation of T cellsSeon-Hee Kim, Sang-Yoon Park, Myong Cheol Lim, et al.Immunotherapy|November 30, 2020
Pembrolizumab rechallenge in squamous non-small-cell lung cancer and HIV-positivity: a case reportGiorgia Guaitoli, Fausto Barbieri, Monica Barbolini, et al.Immunotherapy|December 15, 2018
Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin®-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancerLingdi Zhao, Tiepeng Li, Yonghao Yang, et al.Immunotherapy|March 15, 2018
Tralokinumab for the treatment of severe, uncontrolled asthma: the ATMOSPHERE clinical development programReynold A Panettieri, Millie Wang, Martin Braddock, et al.Immunotherapy|December 18, 2013
Conference scene: New research directions in innate immunityChristopher James Kevin WardImmunotherapy|December 18, 2013
In vitro assessment of the effects of anti-HER2 monoclonal antibodies on proliferation of HER2-overexpressing breast cancer cellsFathollah Tahmasebi, Tohid Kazemi, Mohammad Mehdi Amiri, et al.Pageof 188